Kantor, Guy
Institut Bergonié
2 papers on CoChat
Most cited papers
- Verified
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Baumert, B. G., Hegi, M. E., van den Bent, M. J., von Deimling, A., Gorlia, T., Hoang-Xuan, K., Brandes, A. A., Kantor, G., Taphoorn, M. J. B., Hassel, M. B., et al. (2016) · The Lancet Oncology
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 495
- Verified
First-in-Human Study Testing a New Radioenhancer Using Nanoparticles (NBTXR3) Activated by Radiation Therapy in Patients with Locally Advanced Soft Tissue Sarcomas
Bonvalot, S., Le Pechoux, C., De Baere, T., Kantor, G., Buy, X., Stoeckle, E., Terrier, P., Sargos, P., Coindre, J. M., Lassau, N., et al. (2017) · Clinical Cancer Research
Sarcoma Diagnosis and TreatmentRadiation Therapy and Dosimetry
Cited by 243
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free